Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash Items
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Silo Pharma (SILO) Long-Term Debt Issuances (2019 - 2021)

Historic Long-Term Debt Issuances for Silo Pharma (SILO) over the last 4 years, with Q1 2021 value amounting to $2366.0.

  • Silo Pharma's Long-Term Debt Issuances fell 8422.67% to $2366.0 in Q1 2021 from the same period last year, while for Mar 2021 it was $22366.0, marking a year-over-year decrease of 9311.82%. This contributed to the annual value of $35000.0 for FY2020, which is 8813.56% down from last year.
  • Silo Pharma's Long-Term Debt Issuances amounted to $2366.0 in Q1 2021, which was down 8422.67% from $20000.0 recorded in Q2 2020.
  • In the past 5 years, Silo Pharma's Long-Term Debt Issuances registered a high of $270000.0 during Q4 2019, and its lowest value of $2366.0 during Q1 2021.
  • Its 3-year average for Long-Term Debt Issuances is $76841.5, with a median of $17500.0 in 2020.
  • Over the last 5 years, Silo Pharma's Long-Term Debt Issuances had its largest YoY gain of 8422.67% in 2021, and its largest YoY loss of 8422.67% in 2021.
  • Quarter analysis of 3 years shows Silo Pharma's Long-Term Debt Issuances stood at $270000.0 in 2019, then plummeted by 92.59% to $20000.0 in 2020, then crashed by 88.17% to $2366.0 in 2021.
  • Its Long-Term Debt Issuances was $2366.0 in Q1 2021, compared to $20000.0 in Q2 2020 and $15000.0 in Q1 2020.